Replacing the mercury manometer with an oscillometric device in a hypertension clinic: implications for clinical decision making

European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults

(2010) Eoin OʼBrien et al.   BLOOD PRESSURE MONITORING

Development and validation of a blinded hybrid device according to the European Hypertension Society protocol: Nissei DM-3000

(2010) F Tasker et al.   JOURNAL OF HUMAN HYPERTENSION

Validation of three professional devices measuring office blood pressure according to three different methods: the Omron BP10, the Omron HBP T105 and the Pic Indolor Professional

(2010) Roland Asmar et al.   JOURNAL OF HYPERTENSION

Validation of the A&D UM-101 professional hybrid device for office blood pressure measurement according to the International Protocol

(2009) George S. Stergiou et al.   BLOOD PRESSURE MONITORING

Assessing the Validity of the Omron HEM-907XL Oscillometric Blood Pressure Measurement Device in a National Survey Environment

(2009) Yechiam Ostchega et al.   Journal of Clinical Hypertension

Unreliable oscillometric blood pressure measurement: prevalence, repeatability and characteristics of the phenomenon

(2009) G S Stergiou et al.   JOURNAL OF HUMAN HYPERTENSION

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring

(2009) Gianfranco Parati et al.   JOURNAL OF HYPERTENSION

Office Blood Pressure Measurement With Electronic Devices: Has the Time Come?

(2008) G. S. Stergiou   AMERICAN JOURNAL OF HYPERTENSION

Validation of the Microlife Watch BP Office professional device for office blood pressure measurement according to the International protocol

(2008) George S. Stergiou et al.   BLOOD PRESSURE MONITORING

Franz Volhard lecture: should doctors still measure blood pressure? The missing patients with masked hypertension

(2008) Thomas G Pickering et al.   JOURNAL OF HYPERTENSION

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE